Gupta G, Maikhuri J P, Dwivedi A K, Setty B S
Division of Endocrinology, Central Drug Research Institute, Lucknow, India.
Contraception. 1997 Dec;56(6):395-400. doi: 10.1016/s0010-7824(97)00187-x.
Marker enzymes of Sertoli and germ cells were estimated to study the mechanism of action of antispermatogenic compound CDRI 84/35 in adult male rat testis. Animals were killed after 22, 41, and 64 days of treatment with antispermatogenic dose of CDRI 84/35 in order to evaluate the effect of the compound on spermatid, spermatocyte, and spermatogonial stages, respectively. Studies were also extended to a recovery period of 90 days. Results indicate a direction action of the compound on germ cells, with no apparent effect on Sertoli cells. Studies also show a massive depletion of postmeiotic germ cells after the treatment, with some damage to premeiotic germ cells as well. Reversibility of the compound was partial, with the marker enzymes of pre- and postmeiotic germ cells not being restored to control levels after withdrawal of treatment.
为研究抗生精化合物CDRI 84/35对成年雄性大鼠睾丸的作用机制,对支持细胞和生殖细胞的标记酶进行了评估。在用抗生精剂量的CDRI 84/35治疗22、41和64天后处死动物,以分别评估该化合物对精子细胞、精母细胞和精原细胞阶段的影响。研究还延长至90天的恢复期。结果表明该化合物对生殖细胞有定向作用,对支持细胞无明显影响。研究还显示,治疗后减数分裂后生殖细胞大量耗竭,减数分裂前生殖细胞也有一些损伤。该化合物的可逆性是部分的,治疗停止后,减数分裂前和减数分裂后生殖细胞的标记酶未恢复到对照水平。